Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Innovative Growth | Inspire Medical Systems shows strong financial health with 28.5% revenue growth, expanding its presence in the obstructive sleep apnea treatment market |
Product Pipeline | Explore the potential impact of Inspire V, a new product set for full launch in 2025, poised to drive performance beyond current projections |
Market Expansion | Delve into Inspire's strategic growth, adding 66 new U.S. centers and 13 sales territories, signaling aggressive market penetration efforts |
Financial Outlook | Analysts project price targets ranging from $190 to $270, with the company forecasting 17-19% sales increase and positive EPS guidance for 2025 |
Metrics to compare | INSP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipINSPPeersSector | |
---|---|---|---|---|
P/E Ratio | 57.5x | −3.3x | −0.5x | |
PEG Ratio | 0.11 | 0.06 | 0.00 | |
Price/Book | 6.0x | 2.3x | 2.6x | |
Price / LTM Sales | 4.5x | 3.3x | 3.2x | |
Upside (Analyst Target) | 57.3% | 39.3% | 42.0% | |
Fair Value Upside | Unlock | 17.2% | 6.6% | Unlock |